BioSpace News Archive

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, announced today that is has selected LaVoieHealthScience (LHS) as its investor relations and corporate communications Agency of Record.

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced that it has commenced a proposed public offering of $110,000,000 in shares of its common stock.

Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, today provided a corporate update and reported financial results for the third quarter ended September 30, 2019.

Endo International plc (NASDAQ: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the original Biologics License Application (BLA) for collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the buttocks.

A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article on challenges for medical device manufacturers in emerging markets.

Newly appointed board members include: The Honorable Paul W. Armstrong, J.S.C. (Ret.), M.A., J.D., LLM, as Chairman, and Lili Brillstein, MPH, Bill Burns, ACAS, MAAA, and Brian S. Kern, Esq. as members.

Comprehensive review affirms high-quality clinical and operational standards

The Company Reports Net Income of $236,462 For The Three-Month Period Ended September 30, 2019

The company announces a new brand position and corporate identity consistent with providing hospitals with connectivity between transport and pharmacy automation solutions leading to better patient outcomes

Centric Health Corporation commenced trading on Toronto Stock Exchange on September 1, 2009.